全文获取类型
收费全文 | 1336469篇 |
免费 | 103125篇 |
国内免费 | 6002篇 |
专业分类
耳鼻咽喉 | 18922篇 |
儿科学 | 45095篇 |
妇产科学 | 36009篇 |
基础医学 | 189508篇 |
口腔科学 | 34513篇 |
临床医学 | 118791篇 |
内科学 | 267146篇 |
皮肤病学 | 28676篇 |
神经病学 | 103795篇 |
特种医学 | 53397篇 |
外国民族医学 | 712篇 |
外科学 | 202138篇 |
综合类 | 35061篇 |
现状与发展 | 20篇 |
一般理论 | 379篇 |
预防医学 | 99630篇 |
眼科学 | 29538篇 |
药学 | 100882篇 |
64篇 | |
中国医学 | 5404篇 |
肿瘤学 | 75916篇 |
出版年
2021年 | 11042篇 |
2019年 | 11149篇 |
2018年 | 15279篇 |
2017年 | 11784篇 |
2016年 | 12725篇 |
2015年 | 14983篇 |
2014年 | 20396篇 |
2013年 | 28922篇 |
2012年 | 40277篇 |
2011年 | 42745篇 |
2010年 | 25661篇 |
2009年 | 23987篇 |
2008年 | 39633篇 |
2007年 | 42259篇 |
2006年 | 42521篇 |
2005年 | 41457篇 |
2004年 | 39603篇 |
2003年 | 38414篇 |
2002年 | 37484篇 |
2001年 | 65094篇 |
2000年 | 67702篇 |
1999年 | 57730篇 |
1998年 | 16043篇 |
1997年 | 14617篇 |
1996年 | 14856篇 |
1995年 | 14056篇 |
1994年 | 13262篇 |
1993年 | 12110篇 |
1992年 | 44932篇 |
1991年 | 43788篇 |
1990年 | 42508篇 |
1989年 | 40366篇 |
1988年 | 37157篇 |
1987年 | 36434篇 |
1986年 | 33831篇 |
1985年 | 32433篇 |
1984年 | 24247篇 |
1983年 | 20356篇 |
1982年 | 11770篇 |
1981年 | 10735篇 |
1979年 | 21421篇 |
1978年 | 14858篇 |
1977年 | 12553篇 |
1976年 | 11704篇 |
1975年 | 12658篇 |
1974年 | 14706篇 |
1973年 | 14145篇 |
1972年 | 12964篇 |
1971年 | 11750篇 |
1970年 | 11063篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
941.
Y. Le Meur M. Büchler A. Thierry S. Caillard F. Villemain S. Lavaud I. Etienne P.-F. Westeel B. H. de Ligny L. Rostaing E. Thervet J. C. Szelag J.-P. Rérolle A. Rousseau G. Touchard P. Marquet 《American journal of transplantation》2007,7(11):2496-2503
Efficacy and safety of mycophenolate mofetil (MMF) may be optimized with individualized doses based on therapeutic monitoring of its active metabolite, mycophenolic acid (MPA). In this 12-month study, 137 renal allograft recipients from 11 French centers receiving basiliximab, cyclosporine A, MMF and corticosteroids were randomized to receive either concentration-controlled doses or fixed-dose MMF. A novel Bayesian estimator of MPA AUC based on three-point sampling was used to individualize doses on posttransplant days 7 and 14 and months 1, 3 and 6. The primary endpoint was treatment failure (death, graft loss, acute rejection and MMF discontinuation). Data from 65 patients/group were analyzed. At month 12, the concentration-controlled group had fewer treatment failures (p = 0.03) and acute rejection episodes (p = 0.01) with no differences in adverse event frequency. The MMF dose was higher in the concentration-controlled group at day 14 (p < 0.0001), month 1 (p < 0.0001) and month 3 (p < 0.01), as were median AUCs on day 14 (33.7 vs. 27.1 mg*h/L; p = 0.0001) and at month 1 (45.0 vs. 30.9 mg*h/L; p < 0.0001). Therapeutic MPA monitoring using a limited sampling strategy can reduce the risk of treatment failure and acute rejection in renal allograft recipients 12 months posttransplant with no increase in adverse events. 相似文献
942.
K Parsi T Exner D E Connor D D F Ma J E Joseph 《European journal of vascular and endovascular surgery》2007,34(6):731-740
OBJECTIVES: To investigate the in vitro effects of Sodium Tetradecyl Sulphate (STS) and Polidocanol (POL) on clotting tests, clotting factors, platelets and microparticles. MATERIALS AND METHODS: Platelet rich (PRP) and platelet poor (PPP) plasmas were incubated with varying concentrations of STS and POL. Clotting tests, platelet/plasma turbidity, and microparticle studies were performed. Specimens were mixed with individual factor deficient plasmas and clotting factor activities were studied. RESULTS: STS at high concentrations (>0.3%) destroyed platelets, microparticles and the clotting factors V, VII and X. It prolonged all clotting tests including prothrombin time (PT), activated partial thromboplastin time (APTT), non-activated partial thromboplastin time (NAPTT), thrombin time (TT), factor Xa clotting time (XACT) and surface activated clotting time (SACT). Higher concentrations of POL were required to achieve some anticoagulant activity. Low sclerosant concentrations shortened XACT and SACT, and induced release of procoagulant platelet derived microparticles. Increased exposure time resulted in increased procoagulant activity. STS at concentrations higher than 0.5% precipitated a complex containing apolipoprotein b and fibrinogen. CONCLUSIONS: Detergent sclerosants affect the clotting mechanism by interfering with clotting factor activities, procoagulant phospholipids and platelet derived microparticles. STS has more anticoagulant activity than POL in high concentrations. Low concentration sclerosants demonstrate procoagulant activity. 相似文献
943.
P. Neary C. Hurson D. O. Briain A. Brabazon D. Mehigan T. V. Keaveny S. Sheehan 《Colorectal disease》2007,9(2):166-172
OBJECTIVE: Colonic infarction is a recognized complication of abdominal aortic aneurysm (AAA) surgery. The clinical difficulty in establishing the diagnosis combined with the patient's poor physiological status is usually associated with a fatal outcome. We assessed our experience with this problem to identify a possible risk factor profile for these patients. METHOD: Patients records were identified from the operative logs, intensive care unit, Hospital Inpatient Enquiry system and vascular unit databases over a 6-year period. RESULTS: A total of 405 patients underwent AAA repair during this period; 140 as emergency ruptures. Nine patients were identified from the databases with known colonic infarction (2.2%). One was a woman. The mean age was 70 years. Seven patients had emergency ruptures (5%). Twenty independent risk factors were analysed using univariate and multivariate logistic regression models. Significant risk factors identified by using a multivariate analysis included the nature of the presenting patient, preoperative hypotension, prolonged cross-clamp time, intra-operative ischaemia and postoperative acidosis. Confirmatory diagnosis was made by colonoscopy in eight patients. One patient survived following the salvage surgery. The mean duration of survival was 10.5 days. The overall mortality was 89% of patients. CONCLUSION: In our unit infrarenal AAA repair has a 2.2% rate of colonic infarction. A definitive diagnosis is best made by colonoscopy. A risk factor profile for the development of colonic infarction may be constructed on the basis of specific clinical parameters. Earlier intervention on the basis of this profile may ultimately reduce the current excessive mortality. 相似文献
944.
945.
946.
M. Diez L. Favaloro A. Bertolotti J. M. Burgos C. Vigliano M. P. Lastra M. J. Levin A. Arnedo C. Nagel A. G. Schijman R. R. Favaloro 《American journal of transplantation》2007,7(6):1633-1640
Heart transplantation (HTx) is a useful therapy for end‐stage Chaga? cardiomyopathy; however, Chagas reactivation remains a mayor complication. Parasitological methods offer poor diagnostic sensitivity, and use of more sensitive tools such as the Polymerase chain reaction (PCR) is usually necessary. In the present study, reactivation incidence and PCR usefulness for early reactivation diagnosis, as well as for treatment response evaluation during follow‐up, were analyzed using Strout parasite detection test, in 10 of 222 consecutive HTx patients suffering Chagas cardiomyopathy. PCR strategies targeted to minicircle sequences (kDNA, detection limit 1 parasite/ 10 mL blood) and miniexon genes (SL‐DNA, 200 parasite/10 mL) were performed to compare parasite burdens between samples. No patients received prophylactic antiprotozoal therapy (benznidazole). Five patients (50%) exhibited clinical reactivation within a mean period of 71.6 days; positive Strout results were observed in most cases presenting clinical manifestations. kDNA‐PCR was positive 38–85 days before reactivation, whereas SLDNA‐PCR became positive only 7–21 days later, revealing post‐HTx parasitic load enhancement present prior to clinical reactivation development. Reactivations were successfully treated with benznidazole and generated negative PCR results. Results observed in this study indicate the value of PCR testing for an early diagnosis of Chagas reactivation as well as for monitoring treatment efficacy. 相似文献
947.
948.
949.
950.